HomeContact UsSearchGenzyme Corporate
Our TrialsOur Trial ResultsAbout The Registry
clinical research
Visit this section to view our ongoing trials.
Visit this section to view our completed trials.

Genzyme's clinical research program is focused on the areas of medicine where it markets commercial products, namely rare inherited disorders, kidney disease, orthopaedics, cancer, transplant, and immune disease. It also conducts research in cardiovascular disease, neurodegenerative diseases, and other areas of unmet medical need. The company strives to maintain product candidates across the stages of the development spectrum, from pre-clinical research to post-marketing studies.

Genzyme is committed to transparency in medical research. We have registered all of our active, company-sponsored hypothesis-testing clinical trials on the National Institutes of Health Web site www.clinicaltrials.gov. This information is available here on our site, as well.

Clinical trial results for hypothesis-testing trials for all marketed drugs and biologics will be listed both here and on the Pharmaceutical Research and Manufacturers of America (PhRMA) Web site www.clinicalstudyresults.org. Currently, we include results for eight products, and we are working to gather and add results for several more products over the coming months.

Contact Information

Genzyme Corporation
500 Kendall Street
Cambridge, MA 02142
T:617 252 7500
F:617 252 7600
Contact Us
Notice of Information Practices | Terms and Conditions of Use | Privacy Policy   | © 2016 Genzyme Corporation, a Sanofi company. All rights reserved.